The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibition of four human serine proteases by substituted benzamidines.EBI
TBA
Development of new cyclic plasmin inhibitors with excellent potency and selectivity.EBI
Philipps University Marburg
 
Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitorsEBI
TBA
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.EBI
Johnson & Johnson Pharmaceutical Research And Development
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.EBI
Johnson & Johnson Pharmaceutical Research And Development
A novel series of potent and selective small molecule inhibitors of the complement component C1s.EBI
3-Dimensional Pharmaceuticals
 
Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazolesBDB
Hacettepe University